yourstate.us
21 CFR 1150.15

§ 1150.15 Disputes.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 1150.15, § 1150.15 Disputes, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/91596
Permanent ID
ys:prov:91596@1
SHA-256
550fe7101186034e257d574a066df38101f56a3cef593b8b530a88c94f3a29b5

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) A domestic tobacco manufacturer or importer may dispute an FDA assessment. The dispute must include the basis for the dispute, and the dispute must be: (1) Submitted in writing; (2) Received by FDA no later than 45 days after the date on the assessment notification; (3) Legible and in English; and (4) Sent to the address found on our website (https://www.fda.gov/tobacco-products/manufacturing/tobacco-user-fees). (b) If FDA determines that there was an error related to the assessment and the assessment was too high, FDA will refund the amount assessed in error to the domestic manufacturer or importer. (c) FDA will provide a dated, written response, and its response will provide information about how to submit a request for further Agency review. (d) A request for further Agency review under § 10.75 of this chapter may be submitted. Such a request must be submitted in writing by the domestic manufacturer or importer and received by FDA within 30 days from the date on FDA's response. The request for further Agency review must be legible, in English, and submitted to the address found on our website (https://www.fda.gov/tobacco-products/manufacturing/tobacco-user-fees).

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.